If your knees have started dictating your life, when you sit, how you climb stairs, whether you can keep up with your grandkids at the park, you already know that knee osteoarthritis is more than an occasional ache. It’s a daily negotiation with pain.
For decades, the treatment path for knee osteoarthritis has looked fairly predictable: over-the-counter pain relievers, physical therapy, steroid or gel injections, and eventually, if nothing else works, a total knee replacement. But a newer, minimally invasive procedure called genicular artery embolization (GAE) is changing that script. It’s giving patients an option between “manage the pain” and “replace the joint,” and it’s starting to catch the attention of insurers, too.
This article walks through what osteoarthritis actually is, how GAE works, what the research says about its effectiveness, who tends to be a good candidate, and, perhaps most importantly, how you can improve your odds of getting it covered by insurance.
What Is Osteoarthritis?
Osteoarthritis (OA) is the most common form of arthritis, and the knee is one of its favorite targets. It develops when the cartilage that cushions the ends of your bones gradually wears down, leaving bone to grind against bone. The result is pain, stiffness, swelling, and, over time, a noticeable loss of mobility.
“Osteoarthritis isn’t just wear and tear from getting older. It’s a whole-joint disease that involves the cartilage, the bone underneath it, the joint lining, and even the surrounding muscles and ligaments,” explains Sadia Saeed, MD, physician and medical advisor with Welzo. She notes that inflammation plays a bigger role in OA than many people realize, which is part of why newer treatments targeting inflamed blood vessels in the joint, like GAE, are generating so much interest.
The numbers behind knee OA are sobering. Research using national health survey data shows the condition affects roughly a fifth to nearly a third of adults over 45 in the knee alone, and global estimates put the total number of people living with osteoarthritis worldwide at more than 600 million, a figure that has more than doubled since 1990. A person’s lifetime risk of developing OA in at least one joint runs as high as 40% for men and 47% for women, and that risk climbs even further for people with obesity.
Common symptoms include:
- Pain that worsens with activity and eases with rest, at least in the earlier stages
- Morning stiffness that typically loosens up within 30 minutes
- Swelling around the joint
- A grinding or crackling sensation with movement
- Reduced range of motion that makes stairs, kneeling, or long walks harder
Left untreated, knee OA tends to progress. That’s exactly why so many patients eventually start asking their doctors what else is out there beyond injections and ibuprofen.
What Is GAE, a New Treatment for Knee Osteoarthritis?
Genicular artery embolization is a minimally invasive, image-guided procedure typically performed by an interventional radiologist. Instead of operating on the joint itself, the physician threads a thin catheter through the femoral artery in the groin or wrist and guides it to the small genicular arteries that supply blood to the knee.
Here’s the idea behind it: in an arthritic knee, those blood vessels often become abnormally numerous and overactive, a condition called synovial hypervascularity. This extra blood flow feeds inflammation and is thought to sensitize the nerve endings responsible for pain. During GAE, the physician injects tiny embolic particles, roughly the size of a grain of sand, into these overactive vessels to reduce blood flow to the inflamed lining of the joint. Less inflammation tends to mean less pain.
The procedure is typically done on an outpatient basis, takes about one to two hours, and is performed under local anesthesia with mild sedation. Most patients go home the same day and are back to normal activities within a few days, a sharp contrast to the months-long recovery that follows a total knee replacement.
A few things make GAE stand out from other knee OA treatments:
- It doesn’t remove any joint tissue, so it doesn’t rule out knee replacement surgery later if needed
- It targets the inflammation driving the pain rather than just masking symptoms
- Downtime is measured in days, not months
- It’s an option for patients who aren’t ready for, or aren’t candidates for, joint replacement
GAE isn’t brand new. It builds on embolization techniques that interventional radiologists have used for years to treat other conditions, from uterine fibroids to joint bleeding in hemophilia patients. What’s new is applying that same science specifically to osteoarthritis pain, and the results so far have prompted a wave of clinical research.
How GAE Differs From Injections and Surgery
Corticosteroid and hyaluronic acid injections work by temporarily calming inflammation or lubricating the joint, but their effects usually fade within a few months and require repeat visits. Knee replacement surgery, meanwhile, is highly effective for advanced OA but comes with a lengthy recovery, rehabilitation, and the inherent risks of major surgery. GAE occupies the middle ground: more durable than injections, far less invasive than surgery.
Research on GAE’s Effectiveness for Knee Arthritis
The evidence base for GAE has grown steadily. Data drawn from clinical registries shows a technical success rate of about 99.7% for the procedure itself, meaning physicians are nearly always able to successfully access and treat the target vessels. Just as notable, over a two-year follow-up period, only around 5.2% of patients who underwent GAE went on to need a total knee replacement, and roughly 8.3% required a repeat GAE procedure. Side effects tend to be mild, with temporary skin discoloration near the catheter site being the most commonly reported issue.
Academic institutions have taken note. Northwestern University is currently recruiting patients for a study evaluating GAE specifically in people with mild-to-moderate knee osteoarthritis, and a separate multi-year prospective registry, known as RAMBO, is underway at the Joint & Vascular Institute to track long-term outcomes. Earlier trial work out of Denmark, part of the GETKO study, examined GAE as a pain treatment for mild to moderate knee OA and helped lay the groundwork for the current wave of U.S.-based research. A completed study at UCLA also looked specifically at the safety and effectiveness of the procedure for symptomatic knee OA.
Taken together, this growing body of research points to a few consistent themes:
- Patients frequently report meaningful pain reduction within weeks of the procedure
- Improvements tend to persist well beyond what injections typically offer
- Complication rates remain low compared to surgical alternatives
- Researchers are still working to define exactly which patients benefit most
It’s worth being honest about the limits of the evidence, too. Much of the strongest data still comes from registries and smaller trials rather than large, multi-center randomized studies, and long-term outcomes beyond a few years are still being tracked. That’s part of why ongoing trials matter so much, and why most physicians currently recommend GAE as an option for patients who haven’t found lasting relief from conservative treatments rather than as a universal first-line therapy.
Could GAE Be Right for You?
Not every knee OA patient is an ideal candidate for GAE, and figuring out whether it’s worth pursuing usually starts with an honest look at what you’ve already tried.
“GAE tends to make the most sense for patients who have moderate knee osteoarthritis, have already tried conservative treatments like physical therapy, anti-inflammatory medications, or injections without lasting relief, and either want to delay surgery or aren’t good candidates for one,” says Anita Gupta, DO, MPP, PharmD, FASA, board-certified anesthesiologist, pharmacist and expert in health policy and pain medicine. She adds that patients with advanced bone-on-bone arthritis or significant joint deformity may still be better served by surgical options, which is why a thorough evaluation by an interventional radiologist or pain specialist matters before moving forward.
A few questions worth discussing with your doctor:
- Have I exhausted conservative treatments like physical therapy, weight management, and injections?
- Is my osteoarthritis classified as mild to moderate, or has it progressed to advanced, bone-on-bone disease?
- Am I trying to delay or avoid a knee replacement, whether for medical or personal reasons?
- Do I have any bleeding disorders, severe vascular disease, or other conditions that might make embolization risky?
- What does imaging of my knee show about inflammation and blood vessel activity?
Anecdotally, many patients who pursue GAE describe years of cycling through injections that helped for a few months before the pain crept back. For someone in their 50s who isn’t ready to consider surgery, or someone with health conditions that make major surgery riskier, GAE can offer a genuine middle path. That said, it isn’t a guaranteed fix, and results vary from person to person, which is exactly why a candid conversation with a specialist matters more than anything you read online.
Is GAE for Knee Osteoarthritis Covered by Insurance?
This is usually the first practical question patients ask once they’ve decided GAE sounds promising, and the honest answer is: it depends, but coverage is becoming more common.
As of 2026, Original Medicare doesn’t have a single nationwide coverage policy specifically written for GAE. Instead, coverage decisions run through Local Coverage Determinations managed by regional Medicare Administrative Contractors, which means whether GAE is covered can vary depending on where you live and which contractor oversees your region. Private insurers are similarly inconsistent. Some plans already recognize GAE as medically necessary for knee osteoarthritis when conservative treatments have failed, while others still classify it as an emerging or investigational procedure and may deny initial claims.
The encouraging trend is that as more clinical data accumulates, more insurers are shifting toward covering GAE, viewing it as a cost-effective alternative to the repeated injections and eventual joint replacements many patients otherwise cycle through. Coverage is not automatic, but it is increasingly achievable with the right groundwork.
Steps that tend to improve your chances of approval:
- Document every conservative treatment you’ve tried, including dates, medications, and outcomes
- Get imaging (X-ray or MRI) that clearly shows the extent of your osteoarthritis
- Ask your physician to write a clear letter of medical necessity connecting your history to the recommendation for GAE
- Confirm whether your specific plan requires prior authorization, and submit that paperwork before scheduling
- Be prepared to appeal an initial denial. Many insurance denials are overturned on appeal when additional documentation is provided
- Ask your provider’s office if they have staff experienced in navigating GAE pre-authorization, since this is still a relatively new procedure for many claims processors
If your insurer denies coverage and an appeal doesn’t succeed, some clinics offer payment plans, and it’s worth asking your provider directly about self-pay pricing and financing options before ruling GAE out entirely.
The Bottom Line on Knee Osteoarthritis Treatment
Knee osteoarthritis doesn’t have to mean choosing between living with chronic pain or committing to major surgery. Genicular artery embolization has emerged as a legitimate middle-ground option, backed by a growing stack of clinical research, offering many patients meaningful, longer-lasting relief with a fraction of the downtime that surgery requires.
It isn’t right for everyone, and insurance coverage still requires some legwork, but neither of those facts should discourage you from asking your doctor whether you’re a candidate. Bring your imaging, your treatment history, and your questions to that appointment. The more informed you are walking in, the better positioned you’ll be to get both the treatment and the coverage you need.
Also Read | Why Pilates Is Worth It: 7 Benefits Backed by Physical Therapists
